Search Results - "GUINDO, Ando B"

A Field Trial to Assess a Blood-Stage Malaria Vaccine by Thera, Mahamadou A, Doumbo, Ogobara K, Coulibaly, Drissa, Laurens, Matthew B, Ouattara, Amed, Kone, Abdoulaye K, Guindo, Ando B, Traore, Karim, Traore, Idrissa, Kouriba, Bourema, Diallo, Dapa A, Diarra, Issa, Daou, Modibo, Dolo, Amagana, Tolo, Youssouf, Sissoko, Mady, Sissoko, Mahamadou S, Niangaly, Amadou, Takala-Harrison, Shannon, Lyke, Kirsten E, Wu, Yukun, Blackwelder, William C, Godeaux, Olivier, Vekemans, Johan, Dubois, Marie-Claude, Ballou, W. Ripley, Cohen, Joe, Thompson, Darby, Dube, Tina, Soisson, Lorraine, Diggs, Carter L, House, Brent, Lanar, David E, Dutta, Sheetij, Heppner, D. Gray, Plowe, Christopher V

“…In this study of 400 children in Mali, an adjuvanted vaccine based on an apical membrane antigen 1 from the 3D7 strain of Plasmodium falciparum (a blood-stage…”
Get full text

Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial by Laurens, Matthew B, Thera, Mahamadou A, Coulibaly, Drissa, Ouattara, Amed, Kone, Abdoulaye K, Guindo, Ando B, Traore, Karim, Traore, Idrissa, Kouriba, Bourema, Diallo, Dapa A, Diarra, Issa, Daou, Modibo, Dolo, Amagana, Tolo, Youssouf, Sissoko, Mahamadou S, Niangaly, Amadou, Sissoko, Mady, Takala-Harrison, Shannon, Lyke, Kirsten E, Wu, Yukun, Blackwelder, William C, Godeaux, Olivier, Vekemans, Johan, Dubois, Marie-Claude, Ballou, W Ripley, Cohen, Joe, Dube, Tina, Soisson, Lorraine, Diggs, Carter L, House, Brent, Bennett, Jason W, Lanar, David E, Dutta, Sheetij, Heppner, D Gray, Plowe, Christopher V, Doumbo, Ogobara K

“…The FMP2.1/AS02A candidate malaria vaccine was tested in a Phase 2 study in Mali. Based on results from the first eight months of follow-up, the vaccine…”
Get full text

Variation in the circumsporozoite protein of Plasmodium falciparum: vaccine development implications by Gandhi, Kavita, Thera, Mahamadou A, Coulibaly, Drissa, Traoré, Karim, Guindo, Ando B, Ouattara, Amed, Takala-Harrison, Shannon, Berry, Andrea A, Doumbo, Ogobara K, Plowe, Christopher V

“…The malaria vaccine candidate RTS,S/AS01 is based on immunogenic regions of Plasmodium falciparum circumsporozoite protein (CSP) from the 3D7 reference strain…”
Get full text

Correction: Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications by Gandhi, Kavita, Thera, Mahamadou A, Coulibaly, Drissa, Traoré, Karim, Guindo, Ando B, Ouattara, Amed, Takala-Harrison, Shannon, Berry, Andrea A, Doumbo, Ogobara K, Plowe, Christopher V

“…[This corrects the article DOI: 10.1371/journal.pone.0101783.]…”
Get full text

Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial by Thera, Mahamadou A, Doumbo, Ogobara K, Coulibaly, Drissa, Diallo, Dapa A, Kone, Abdoulaye K, Guindo, Ando B, Traore, Karim, Dicko, Alassane, Sagara, Issaka, Sissoko, Mahamadou S, Baby, Mounirou, Sissoko, Mady, Diarra, Issa, Niangaly, Amadou, Dolo, Amagana, Daou, Modibo, Diawara, Sory I, Heppner, D Gray, Stewart, V Ann, Angov, Evelina, Bergmann-Leitner, Elke S, Lanar, David E, Dutta, Sheetij, Soisson, Lorraine, Diggs, Carter L, Leach, Amanda, Owusu, Alex, Dubois, Marie-Claude, Cohen, Joe, Nixon, Jason N, Gregson, Aric, Takala, Shannon L, Lyke, Kirsten E, Plowe, Christopher V

“…The objective was to evaluate the safety, reactogenicity and immunogenicity of the AMA-1-based blood-stage malaria vaccine FMP2.1/AS02A in adults exposed to…”
Get full text

Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial by Thera, Mahamadou A, Doumbo, Ogobara K, Coulibaly, Drissa, Laurens, Matthew B, Kone, Abdoulaye K, Guindo, Ando B, Traore, Karim, Sissoko, Mady, Diallo, Dapa A, Diarra, Issa, Kouriba, Bourema, Daou, Modibo, Dolo, Amagana, Baby, Mounirou, Sissoko, Mahamadou S, Sagara, Issaka, Niangaly, Amadou, Traore, Idrissa, Olotu, Ally, Godeaux, Olivier, Leach, Amanda, Dubois, Marie-Claude, Ballou, W Ripley, Cohen, Joe, Thompson, Darby, Dube, Tina, Soisson, Lorraine, Diggs, Carter L, Takala, Shannon L, Lyke, Kirsten E, House, Brent, Lanar, David E, Dutta, Sheetij, Heppner, D Gray, Plowe, Christopher V

“…The objective was to evaluate the safety and immunogenicity of the AMA1-based malaria vaccine FMP2.1/AS02(A) in children exposed to seasonal falciparum…”
Get full text

Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali by Takala, Shannon L, Coulibaly, Drissa, Thera, Mahamadou A, Dicko, Alassane, Smith, David L, Guindo, Ando B, Kone, Abdoulaye K, Traore, Karim, Ouattara, Amed, Djimde, Abdoulaye A, Sehdev, Paul S, Lyke, Kirsten E, Diallo, Dapa A, Doumbo, Ogobara K, Plowe, Christopher V

“…Malaria vaccines based on the 19-kDa region of merozoite surface protein 1 (MSP-1(19)) derived from the 3D7 strain of Plasmodium falciparum are being tested in…”
Get full text

Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara by Thera, Mahamadou A, Coulibaly, Drissa, Kone, Abdoulaye K, Guindo, Ando B, Traore, Karim, Sall, Abdourhamane H, Diarra, Issa, Daou, Modibo, Traore, Idrissa M, Tolo, Youssouf, Sissoko, Mady, Niangaly, Amadou, Arama, Charles, Baby, Mounirou, Kouriba, Bourema, Sissoko, Mahamadou S, Sagara, Issaka, Toure, Ousmane B, Dolo, Amagana, Diallo, Dapa A, Remarque, Edmond, Chilengi, Roma, Noor, Ramadhani, Sesay, Sanie, Thomas, Alan, Kocken, Clemens H, Faber, Bart W, Imoukhuede, Egeruan Babatunde, Leroy, Odile, Doumbo, Ogobara K

“…The safety and immunogenicity of PfAMA1, adjuvanted with Alhydrogel(®) was assessed in malaria-experienced Malian adults. The malaria vaccine, PfAMA1-FVO…”
Get full text

Next Generation Sequencing to Detect Variation in the Plasmodium falciparum Circumsporozoite Protein by GANDHI, Kavita, THERA, Mahamadou A, COULIBALY, Drissa, TRAORE, Karim, GUINDO, Ando B, DOUMBO, Ogobara K, TAKALA-HARRISON, Shannon, PLOWE, Christopher V

“…The malaria vaccine RTS,S/AS01, based on immunogenic regions of the Plasmodium falciparum circumsporozoite protein (CSP), has partial efficacy against clinical…”
Get full text

Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria by Djimdé, Abdoulaye A, Doumbo, Ogobara K, Traore, Ousmane, Guindo, Ando B, Kayentao, Kassoum, Diourte, Yacouba, Niare-Doumbo, Safiatou, Coulibaly, Drissa, Kone, Abdoulaye K, Cissoko, Yacouba, Tekete, Mamadou, Fofana, Bakary, Dicko, Alassane, Diallo, Dapa A, Wellems, Thomas E, Kwiatkowski, Dominic, Plowe, Christopher V

“…Residents of malaria-endemic areas sometimes spontaneously clear Plasmodium falciparum infection without drug treatment, implying an important role for host…”
Get more information

Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali by Coulibaly, Drissa, Diallo, Dapa A, Thera, Mahamadou A, Dicko, Alassane, Guindo, Ando B, Koné, Abdoulaye K, Cissoko, Yacouba, Coulibaly, Seydou, Djimdé, Abdoulaye, Lyke, Kirsten, Doumbo, Ogobara K, Plowe, Christopher V

“…Treating malaria before immunizing has been standard in malaria vaccine field trials. To assess the impact of this practice on subsequent infection and disease…”
Get more information

Correction: Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications: e0148240 by Gandhi, Kavita, Thera, Mahamadou A, Coulibaly, Drissa, Traore, Karim, Guindo, Ando B, Ouattara, Amed, Takala-Harrison, Shannon, Berry, Andrea A, Doumbo, Ogobara K, Plowe, Christopher V

Get full text

Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial: e79323 by Laurens, Matthew B, Thera, Mahamadou A, Coulibaly, Drissa, Ouattara, Amed, Kone, Abdoulaye K, Guindo, Ando B, Traore, Karim, Traore, Idrissa, Kouriba, Bourema, Diallo, Dapa A

“…Background The FMP2.1/AS02A candidate malaria vaccine was tested in a Phase 2 study in Mali. Based on results from the first eight months of follow-up, the…”
Get full text